Ampio Pharm Stock Target Price and Analyst Consensus
AMPE Stock | USD 0.82 0.01 1.23% |
The current analyst and expert consensus on Ampio Pharm is Buy, with 0 strong buy opinions. The current projected Ampio Pharm target price consensus is 4.0 with 1 analyst opinions. The most common way Ampio Pharm analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Ampio Pharm executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Ampio Pharm. We encourage you to use your own analysis of Ampio Pharm to validate this buy or sell advice. Ampio Pharm buy-or-sell recommendation module provides average expert sentiment on the projected Ampio Pharm target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Ampio Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.
Lowest Forecast 3.64 | Highest Forecast 4.44 | Target Price 4 |
Ampio |
It's important to approach Ampio Pharm's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Ampio Pharm price targets
Ampio Pharm's stock target price is an estimate of its future price, usually made by analysts. Using Ampio Pharm's target price to determine if it is a suitable investment can be done through the following steps:- Look at Ampio Pharm's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ampio Pharm's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Ampio Pharm Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ampio Pharm is a key component of Ampio Pharm valuation and have some predictive power on the future returns of a Ampio Pharm.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ampio Pharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Corona Opportunity Invested few shares | ||
Cash Cows Invested a lot of shares | ||
Business Services Invested over 100 shares | ||
Macroaxis Index Invested few shares | ||
Warren Buffett Holdings Invested over 40 shares | ||
Momentum Invested few shares | ||
Hedge Favorites Invested few shares | ||
Disruptive Technologies Invested over 100 shares | ||
FinTech Invested over 70 shares | ||
Millennials Best Invested over 30 shares | ||
ESG Investing Invested a lot of shares | ||
Artificial Intelligence Invested over 50 shares | ||
Check out Macroaxis Advice on Ampio Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Ampio Stock analysis
When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stocks Directory Find actively traded stocks across global markets |
The data published in Ampio Pharm's official financial statements usually reflect Ampio Pharm's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Ampio Pharm. For example, before you start analyzing numbers published by Ampio accountants, it's critical to develop an understanding of what Ampio Pharm's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Ampio Pharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ampio Pharm's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Ampio Pharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ampio Pharm. Please utilize our Beneish M Score to check the likelihood of Ampio Pharm's management manipulating its earnings.